Testing for growth hormone deficiency in adults: Doing without growth hormone-releasing hormone

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 4, 2012, Pages 300-305

  Kargi, Atil Y ^a   Merriam, George R ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Growth hormone; Growth hormone deficiency; Growth hormone stimulation testing

Indexed keywords

ARGININE; CLONIDINE; CORTICOTROPIN; DOPA; GLUCAGON; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE SECRETAGOGUE; HEXARELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HYDROCORTISONE; HYPERTONIC SOLUTION; IBUTAMOREN; MACIMORELIN; PRALMORELIN; PROPRANOLOL; SOMATOMEDIN C; SOMATOSTATIN;

APPLICATION SITE IRRITATION; CHILDHOOD; DIAGNOSTIC ACCURACY; DRUG EXTRAVASATION; GROWTH HORMONE DEFICIENCY; HEAD INJURY; HORMONAL REGULATION; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; INSULIN HYPOGLYCEMIA; INSULIN TOLERANCE TEST; MULTICENTER STUDY (TOPIC); PROVOCATION TEST; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; SYNDROME CHARGE; VALIDATION PROCESS;

ADULT; ARGININE; FEMALE; GROWTH HORMONE-RELEASING HORMONE; GUIDELINES AS TOPIC; HUMANS; HYPOGLYCEMIA; HYPOPITUITARISM; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; PATIENT SELECTION; UNITED STATES;

EID: 84864575618     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835430da     Document Type: Review

References (63)

1. Simpson H, Savine R, Sö nksen P, et al. Growth hormone replacement therapy for adults: into the new millennium. Growth Horm IGF Res 2002; 12:1-33.
2. Hoffman DM, O'Sullivan AJ, Freund J, Ho KKY. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 1995; 80:72-77.
3. Holmes SJ, Economou G, Whitehouse RW, et al. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994; 78:669-674.
4. Johannsson J, Fowelin J, Landin K, et al. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995; 44:1126-1129.
5. Murata M, Kaji H, Mizuno I, et al. A study of carotid intima-media thickness in GH deficient adults during onset among adults and children. Eur J Endocrinol 2003; 148:333-338.
6. Tomlinson JW, Holden N, Hills RK, et al. for the West Midlands Prospective Hypopituitary Study Group. Association between premature mortality and hypopituitarism. Lancet 2001; 357:425-431.
7. Rosilio M, Blum WF, Edwards DJ, et al. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). J Clin Endocrinol Metab 2004; 89:1684-1693.
8. Salomon F, Ross C, Hesp R, Sö nksen P. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321:1799-1803.
9. Colao A, Di Somma C, Cuocolo A. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 2001; 86:1874-1881.
10. Wuster C, Abs R, Bengtsson B-A, et al. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001; 16:398-405.
11. Gotherstrom G, Elbornsson M, Stibrant-Sunnerhagen K, et al. Ten years of growth hormone replacement normalizes muscle strength in GH-deficient adults. J Clin Endocrinol Metab 2009; 94:809-816.
12. Ghigo E, Aimaretti G, Corneli G. Diagnosis of adult GH deficiency. Growth Horm IGF Res 2008; 18:1-16.
13. Ho KKY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24 h profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64:51-58.
14. Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assays: a 2009 update. Growth Horm IGF Res 2010; 20:8-18.
15. Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 96:1587-1609.
16. Cook DM, Yuen KCJ, Biller BMK, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients 2009 update. Endocrine Pract 2009; 15:580-586.
17. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 2007; 157: 695-770.
18. Freedland ES. Geref1 discontinuation letter, dated 11 July 2008. http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/ucm086077.pdf. [Accessed 3 March 2012].
19. Webb SM, Strasburger CJ,Mo D, et al. Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database. J Clin Endocrinol Metab 2009; 94:392-399.
20. Bidlingmaier M, Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res 2009; 20:19-25.
21. Gabellieri E, Chiovato L, Lage M, et al. Testing for growth hormone deficiency in adults. Front Horm Res 2010; 38:139-144.
22. Longobardi S, Merola B, Pivonello R, et al. Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH deficient patients during childhood. J Clin Endocrinol Metab 1996; 81:1244-1247.
23. Hilding A, Hall K, Wivall-Helleryd IL, et al. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 1999; 84:2013-2019.
24. Hartman ML, Crowe BJ, Biller BMK, et al. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002; 87:477-485.
25. Biller BMK, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002; 87:2067-2079.
26. Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf) 1994; 41:511-516.
27. Clemmons DR. The diagnosis and treatment of growth hormone deficiency in adults. Curr Opinion Endocrinol, Diabetes Obesity 2010; 17:377-383.
28. Gleeson HK, Lissett CA, Shalet SM. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab 2005; 90:1061-1067.
29. Maccario M, Tassone F, Guana C, et al. Effects of short term administration of low dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol 2001; 144:251-256.
30. Darzy KH, Aimaretti G, Wieringa G, et al. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosisof radiation-induced GH deficiency is dependent on the postirradiation time interval. J Clin Endocrinol Metab 2003; 88:95-102.
31. Vestergaard P, Hoeck HC, Jakobsen PE, Laurberg P. Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res 1997; 29:106-110.
32. Binder G, Bosk A, Gass M, et al. Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias. Horm Res 2004; 62:84-87.
33. Shah A, Stanhope R. Matthew D Hazards of pharmacological tests of growth hormone secretion in childhood. Brit Med J 1992; 304:173-174.
34. Hoeck HC, Vestergaard P, Jakobsen PE, Laurberg P. Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur J Endocrinol 1995; 133:305-312.
35. Aimaretti G, Corneli G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone-arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998; 83:1615-1618.
36. Corneli G, Di Somma C, Prodam F, et al. Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol 2007; 157:701-708.
37. Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005; 153:257-264.
38. Yuen KC, Biller BMK, Molitch ME, Cook DM. Clinical review: is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab 2009; 94:2702-2707.
39. Tschopp JF. Stratum Medical Corporation. www.StratumMedical.com. [Accessed 3 March 2012].
40. Mitchell ML, Byrne MJ, Silver J. Growth hormone release by glucagon. Lancet 1969; 1:289-290.
41. Cain JP, Williams GH, Dluhy RG. Glucagon-initiated human growth hormone release: a comparative study. Can Med Assoc J 1972; 107: 617-622.
42. Leong KS, Walker AB, Martin I, et al. An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf) 2001; 54:463-468.
43. Berg C, Meinel T, Lahner H, et al. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol 2010; 162:477-482.
44. Brabant G, Poll EM, Jonsson P, et al. Etiology, baseline characteristics, and biochemical diagnosis of GH deficiency in the adult: are there regional variations? Eur J Endocrinol 2009; 161 (suppl 1):S25-S31.
45. Fernando MA. Relationship between GH response and glycemic fluctuations in the glucagon stimulation test. Growth Horm IGF Res 2009; 19:77-81.
46. Ghigo E, Bartolotta E, Imperiale E, et al. Glucagon stimulates GH secretion after intramuscular but not intravenous administration: evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest 1994; 17:849-854.
47. Goodwin PM, Capildeo R, Harrop JS, et al. The metabolic and hormonal response to glucagon Part 1. Normal subjects. J Neurol Sci 1976; 27:373-380.
48. Kappy MS, Drake A, Gao D, Ratliff R. Assessing adrenal function in primary care settings with a single sample subcutaneous glucagon test. J Peds 2006; 149:682-686.
49. Lim SH, Vasanwala R, Lek N, Yap F. Quantifying the risk of hypoglycaemia in children undergoing the glucagon stimulation test. Clin Endocrinol (Oxf) 2011; 75:489-494.
50. Yuen KCJ, Biller BMK, Legg SE. Clinical characteristics of the glucagon stimulation test (GST) in the evaluation of growth hormone (GH) reserve and hypothalamicpituitary-adrenal (HPA) axis in adults: a multicentered US experience [abstract]. In: Proceedings of the Endocrine Society's 92nd Annual Meeting; 19-22 June 2010; San Diego, Calif, USA.
51. Yuen KCJ, Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives. ISRN Endocrinology 2011; 2011:1-6.
52. Conceicao FL, da Costa e Silva A, Leal Costa AJ, Vaisman M. Glucagon stimulation test for the diagnosis of GH deficiency in adults. J Endocrinol Invest 2003; 26:1065-1070.
53. Yuen KCJ. Clinical characteristics of two dosing regimens of the glucagon stimulation test (GST) in the evaluation of growth hormone (GH) reserve and hypothalamic-pituitary-adrenal(HPA) axis in adults [abstract]. In: Proceedings of the Endocrine Society's 53rd annual meeting; 4-7 June 2011; Boston, USA.
54. Gomez JM, Espadero RM, Escobar-Jimenez F, et al. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol 2002; 56:329-334.
55. Korbonits M, Kaltsas G, Perry LA, et al. Hexarelin as a test of pituitary reserve in patients with pituitary disease. Clin Endocrinol (Oxf) 1999; 51:369-375.
56. Petersenn S, Jung R, Beil FU. Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test. Eur J Endocrinol 2002; 146:667-672.
57. Popovic V. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 2000; 356:1137-1142.
58. Leal A, Lage M, Popovic V, et al. A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test. Clin Endocrinol (Oxf) 2002; 57:377-384.
59. Alaioubi B. Diagnosis of growth hormone deficiency in adults: provocative testing with GHRP-6 in comparison to the insulin tolerance test. Horm Metab Res 2009; 41:238-243.
60. Alaioubi B. Diagnosis of adrenal insufficiency using the GHRP-6 test: comparison with the insulin tolerance test in patients with hypothalamic- pituitaryadrenal disease. Horm Metab Res 2010; 42:198-203.
61. Chihara K, Shimatsu A, Hizuka N, et al. for the KP-102 Study Group. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol 2007; 157:19-27.
62. Garcia JM. AEZS-130 (Macimorelin)-stimulated GH test: Validation of a novel test for the diagnosis of adult growth hormone deficiency (AGHD) [abstract]. In: Proceedings of the Endocrine Society's 94th Annual Meeting; 23-26 June 2012; Houston, TX, USA.
63. Galluzzi F, Quaranta MR, Salti R, et al. Diagnosis of growth hormone deficiency by using the arginine provocative test: is it possible to shorten testing time without altering validity? Horm Res 2009; 72:142-145.